Multidimensional on-line sample preparation of verapamil and its metabolites by a molecularly imprinted polymer coupled to liquid chromatography-mass spectrometry

被引:83
作者
Mullett, WM
Walles, M
Levsen, K
Borlak, J
Pawliszyn, J
机构
[1] Merck Frosst Canada Inc, Pharmaceut Res & Dev, Kirkland, PQ H9H 3L1, Canada
[2] Fraunhofer Inst Toxicol & Aerosol Res, Drug Res & Clin Inhalat, D-30625 Hannover, Germany
[3] Univ Waterloo, Dept Chem, Waterloo, ON N2L 3G1, Canada
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2004年 / 801卷 / 02期
基金
加拿大自然科学与工程研究理事会;
关键词
verapamil; molecularly imprinted polymers;
D O I
10.1016/j.jchromb.2003.11.041
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A new molecularly imprinted polymer (MIP) material was synthesized selective for verapamil and utilized for on-line metabolic screening of this common calcium antagonist in biological samples. Since some metabolites of verapamil have also shown pharmacological properties, a selective and sensitive sample preparation approach that provides a metabolic profile in biologically relevant samples is important. The MIP material was coupled on-line to a restricted access material (RAM) precolumn. The multidimensional nature of this set-up removed large matrix interferents such as proteins from the sample, while the selectivity of the MIP enabled further cleanup of the smaller analytes. The selectivity and extraction efficiency of the MIP for verapamil and its metabolites was evaluated in various biological matrices, such as cell cultures and urine. The experimental set-up with the developed method enabled the direct injection of biological samples for the selective isolation, preconcentration, identification and analysis of verapamil and its phase I metabolites by LC-MSn. This multidimensional approach provided much qualitative information about the metabolic profile of verapamil in various biological matrices. An analytical method was developed for the quantification of verapamil and gallopamil in urine, plasma and cell culture. Acceptable linearity (R-2 = 0.9996, 0.9982 and 0.9762) with an average injection repeatability (n = 3) of 10, 25 and 15% R.S.D. was determined for urine, plasma and cell culture, respectively. This is the first application of the procedure for the selective metabolic screening of verapamil in biological samples. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:297 / 306
页数:10
相关论文
共 42 条